Plexium is harnessing cell-based screening to develop new targeted protein degradation therapies.
Leadership
Mike Grey
Fund
SVF2
Status
Private
Sector
Health Tech
Region
Americas
Vision Fund Team
Plexium is harnessing cell-based screening to develop new targeted protein degradation therapies.
